UltraGreen.ai Limited on Aug, 20 2026 issued a clarification regarding an article published by The Business Times on Aug, 19 2026, stressing that the piece contained analysts’ assumptions not endorsed by the company.

The group noted that regulatory clearances obtained by competitors Zydus Lifesciences and Provepharm are public information and do not necessarily imply imminent product launches or market penetration in the United States.

Management stated that there has been no material change to its business or outlook and reaffirmed its full-year 2026 revenue guidance of US$175 million to US$185 million, with second-half revenue projected to surpass that of the first half.

The announcement was issued by Executive Director and Chief Executive Officer Ravinder Sajwan. Citigroup Global Markets Singapore and DBS Bank, joint issue managers and global coordinators for UltraGreen.ai’s Mainboard listing, assumed no responsibility for the announcement’s contents.